206 related articles for article (PubMed ID: 8825366)
21. Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine.
Caspary WF; Meyne K
Digestion; 1980; 20(3):168-74. PubMed ID: 7390046
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
23. Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids.
Khan KN; Tsutsumi T; Nakata K; Nakao K; Kato Y; Nagataki S
J Gastroenterol Hepatol; 1998 Jun; 13(6):643-50. PubMed ID: 9715409
[TBL] [Abstract][Full Text] [Related]
24. A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon.
Asciutti S; Castellani D; Nardi E; Morelli O; Clementi M; Chistolini F; Gentili G; Setchell KD; O'Connell N; Pellicciari R; Clerici C
Anticancer Res; 2009 Dec; 29(12):4971-9. PubMed ID: 20044604
[TBL] [Abstract][Full Text] [Related]
25. Effects of bile salts on bile formation in rabbits.
Miyasaka K; Kitani K
Life Sci; 1986 Jun; 38(22):2053-61. PubMed ID: 3713438
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrially mediated synergistic cell killing by bile acids.
Rolo AP; Palmeira CM; Wallace KB
Biochim Biophys Acta; 2003 Jan; 1637(1):127-32. PubMed ID: 12527417
[TBL] [Abstract][Full Text] [Related]
27. Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.
Chen G; Fawcett JP; Mikov M; Tucker IG
J Pharm Pharmacol; 2009 Jul; 61(7):953-9. PubMed ID: 19589239
[TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding.
Bouscarel B; Ceryak S; Robins SJ; Fromm H
Lipids; 1995 Jul; 30(7):607-17. PubMed ID: 7564915
[TBL] [Abstract][Full Text] [Related]
29. Bile acids influence hepatic chemiluminescence in normal and oxidative-stressed rats.
Nakashima T; Matsumoto N; Nakajima Y; Ishikawa H; Mitsuyoshi H; Inaba K; Sakai M; Sakamoto Y; Matsumoto M; Shima T; Kashima K; Kitayoshi T; Shimamoto N
J Gastroenterol Hepatol; 1998 Jan; 13(1):81-7. PubMed ID: 9737577
[TBL] [Abstract][Full Text] [Related]
30. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
Hirota I; Chijiiwa K; Noshiro H; Nakayama F
Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
[TBL] [Abstract][Full Text] [Related]
31. Enteral absorption of octreotide.
Fricker G; Drewe J; Vonderscher J; Kissel T; Beglinger C
Br J Pharmacol; 1992 Apr; 105(4):783-6. PubMed ID: 1504712
[TBL] [Abstract][Full Text] [Related]
32. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
33. In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal flora, with particular reference to the mutual conversion between the two bile acids.
Hirano S; Masuda N; Oda H
J Lipid Res; 1981 Jul; 22(5):735-43. PubMed ID: 7288282
[TBL] [Abstract][Full Text] [Related]
34. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
Horowitz NS; Hua J; Powell MA; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2007 Nov; 107(2):344-9. PubMed ID: 17720233
[TBL] [Abstract][Full Text] [Related]
35. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
Rolo AP; Palmeira CM; Holy JM; Wallace KB
Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
[TBL] [Abstract][Full Text] [Related]
36. Biphasic regulation by bile acids of dermal fibroblast proliferation through regulation of cAMP production and COX-2 expression level.
Meng JP; Ceryak S; Aratsu Z; Jones L; Epstein L; Bouscarel B
Am J Physiol Cell Physiol; 2006 Sep; 291(3):C546-54. PubMed ID: 16687473
[TBL] [Abstract][Full Text] [Related]
37. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
Campana G; Pasini P; Roda A; Spampinato S
Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
[TBL] [Abstract][Full Text] [Related]
38. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
39. Further observations on the in vitro metabolism of chenodeoxycholic acid and ursodeoxycholic acid.
Albini E; Marca G; Mellerio G
Arzneimittelforschung; 1982; 32(12):1554-7. PubMed ID: 6891595
[TBL] [Abstract][Full Text] [Related]
40. Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergism.
Rolo AP; Palmeira CM; Wallace KB
Toxicol Lett; 2002 Feb; 126(3):197-203. PubMed ID: 11814708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
